Krause und Pachernegg
Verlag für Medizin und Wirtschaft
Artikel   Bilder   Volltext

Mobile Version
A-  |   A  |   A+
Werbung
 
Dia-Präsentation von SERVIER
EUROPA-Studie (Perindopril) (60 Abbildungen)
Übersicht
Gesamtpräsentation zum Download (rechte Maustaste und "Ziel speichern unter..." klicken)


Zum ersten Bild Abb. 47: EUROPA-Studie - Compliance Abb. 48: EUROPA-Studie - Non Compliance Abb. 49: EUROPA-Studie - Klinische Aussagen Aktuelles Bild - Abb. 50: EUROPA-Studie - KHK Abb. 51: EUROPA-Studie - KHK Abb. 52: EUROPA-Studie - Perindopril - Benefit Abb. 53: EUROPA-Studie - Interaktionsanalyse Zum letzten Bild
Abbildung 50: EUROPA-Studie - KHK
Out of 56 million deaths worldwide in 2001, burden of coronary disease is accounted for 29 % of them, causing deaths in total for 16 million people. In 2020, 37 % of deaths are foreseen as CV deaths. In the European Union, there are 20 million people at risk who have coronary artery disease. Prof. Kim Fox, at the EUROPA study presentation commented that "investigators were particularly excited because the disease they are talking about is the most important disease, and every improvement they can make will have a great impact on the health care in the western world."
 
EUROPA-Studie - KHK
Vorheriges Bild Nächstes Bild   


Abbildung 50: EUROPA-Studie - KHK
Out of 56 million deaths worldwide in 2001, burden of coronary disease is accounted for 29 % of them, causing deaths in total for 16 million people. In 2020, 37 % of deaths are foreseen as CV deaths. In the European Union, there are 20 million people at risk who have coronary artery disease. Prof. Kim Fox, at the EUROPA study presentation commented that "investigators were particularly excited because the disease they are talking about is the most important disease, and every improvement they can make will have a great impact on the health care in the western world."
 
copyright © 2003–2017 Krause & Pachernegg GmbH | Sitemap | Impressum
 
Werbung